Invention Application
- Patent Title: FACTOR XI ANTIBODIES AND METHODS OF USE
-
Application No.: US17450122Application Date: 2021-10-06
-
Publication No.: US20220162339A1Publication Date: 2022-05-26
- Inventor: Maximilian AIGNER , Alexander Wolfgang KOCH , Markus WALDHUBER
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/36
Abstract:
The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI (“Factor XIa”), and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US12012464B2 Factor XI antibodies and methods of use Public/Granted day:2024-06-18
Information query
